Author

G. Kim

Institutions: Mayo Clinic, University of Wisconsin–Madison, Johns Hopkins University, Mayo Clinic in Florida

Observed institutions: Mayo Clinic, University of Wisconsin–Madison, Johns Hopkins University, Mayo Clinic in Florida

OpenAlex ID: A5038541129

Preliminary results of a phase II trial of gefitinib in progressive metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study

2005 · T. J. Hobday, M. Mahoney, et al. · Journal of Clinical Oncology · 27

Works count: 1

Citation count: 27

H-index: 1

I10-index: 1